|
Delayed
Japan Exchange
06:07:56 19/01/2026 GMT
|
5-day change
|
1st Jan Change
|
|
3,270.00 JPY
|
-1.18%
|
 |
-7.74%
|
-2.45%
|
|
19/10/25 |
Daiichi Sankyo Company, Limited Announces DS-3939 Shows Promising Preliminary Clinical Activity in Patients with Advanced Solid Tumors in Phase 1/2 Trial
|
CI
| |
07/10/25 |
Jefferies Adjusts Daiichi Sankyo's Price Target to 6,300 Yen From 6,000 Yen, Keeps at Buy
|
MT
| |
06/10/25 |
Daiichi Sankyo Company, Limited Submits Supplemental New Drug Application to Japan's Ministry of Health, Labour and Welfare for ENHERTU®
|
CI
| |
01/10/25 |
Daiichi Sankyo and Astrazeneca's Supplemental Biologics License Application Accepted in the U.S. for Patients with High-Risk Her2 Positive Early-Stage Breast Cancer Prior to Surgery
|
CI
| |
02/04/25 |
Jefferies Adjusts Daiichi Sankyo's Price Target to 6,000 Yen From 7,600 Yen, Keeps at Buy
|
MT
| |
04/09/24 |
Jefferies Adjusts Daiichi Sankyo's Price Target to 7,600 Yen From 6,600 Yen, Keeps at Buy
|
MT
| |
24/05/24 |
Jefferies Adjusts Daiichi Sankyo’s Price Target to 6,600 Yen From 5,600 Yen, Keeps at Buy
|
MT
| |
21/02/24 |
Jefferies Adjusts Daiichi Sankyo’s Price Target to 5,600 Yen From 4,800 Yen, Keeps at Buy
|
MT
| |
04/12/23 |
Jefferies Upgrades Daiichi Sankyo to Buy From Hold, Adjusts Price Target to 4,800 Yen From 4,300 Yen
|
MT
| |
23/10/23 |
Jefferies Adjusts Daiichi Sankyo’s Price Target to 4,300 Yen From 3,900 Yen, Keeps at Hold
|
MT
| |
25/09/23 |
Jefferies Downgrades Daiichi Sankyo to Hold From Buy, Adjusts Price Target to 1,900 Yen From 2,000 Yen
|
MT
| |
13/07/23 |
Jefferies Adjusts Daiichi Sankyo’s Price Target to 4,800 Yen From 5,300 Yen, Keeps at Buy
|
MT
| |
23/03/23 |
Japanese shares hover near session high on hints of Fed rate pause
|
RE
| |
14/12/22 |
Jefferies Adjusts Daiichi Sankyo's Price Target to 5,300 Yen From 4,300 Yen, Keeps at Buy
|
MT
| |
06/06/22 |
MarketScreener's World Press Review : June 6, 2022
|  |
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
